[1] Oake N, Taljaard M, Van Walraven C, et al. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality[J]. Arch Intern Med, 2010,170:1804-1810.
[2] Alan J.The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital[J]. CMAJ, 2012,184(1): 37-42.
[3] Song X, Bartlett J G, Speck K A, et al. Rising economic impact of Clostridium difficile- associated disease in adult hospitalized patient population[J]. Infect Control Hosp Epidemiol, 2008,29:823-828.
[4] Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis[J]. Lancet,2011,377: 228-241.
[5] 王 羽.医院感染管理办法释义及适用指南[M].北京:中国法制出版社, 2006: 156-180.
[6] Rossini F A,Fagnani R,Leichsenring M L,et al. Successful prevention of the transmission of vancomycin-resistant enterococci in a Brazilian public teaching hospital[J]. Rev Soc Bras Med Trop,2012,45(2):184-188.
[7] Andrew T. Viral enfections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis[J]. Clin Infect Dis,2011,52(4):284-289.
[8] 余 兰,程向群.老年病科医院感染现状及干预对策[J].中华医院感染学杂志,2007,17(9): 1086-1087.
[9] Julia K, Frans T M. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy[J].Clin Microbiol Rev,2013,26(2): 231-254.
[10] David W. Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with clostridium difficile[J]. J Infect Dis,2014,209(9): 1446-1451.